Stockreport

MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance [Yahoo! Finance]

MaxCyte, Inc.  (MXCT) 
PDF Full year 2025 revenue of $33.0 million, at the top of the range of previous preliminary announcement Total cash, cash equivalents and investments were $155.6 million [Read more]